COVID-19 resources - British Association for Cytopathology

RCPath advice on histopathology frozen sections and cytology FNA during infectious disease outbreaks

RCPath article - cytology and the pandemic (July 2020)

RCPath advice on the opening of fresh or unfixed histopathological specimens during infectious disease outbreaks

COVID-19 - recommendations for laboratory work (IBMS, RCPath, ACP and ACB 29th March 2020)

Impact of COVID?19 pandemic on functioning of cytopathology laboratory: Experience and perspective from an academic centre in New York (Jan 2021)

Impact of the COVID-19 pandemic on cytology practice: An international survey in the Asia-Pacific region

Biosafety in the preparation and processing of cytology specimens with potential coronavirus (COVID?19) infection: Perspectives from Taiwan

Cytologic and histologic samples from patients infected by the novel coronavirus 2019 SARS?CoV?2: An italian institutional experience focusing on biosafety procedures

The COVID-19 pandemic: Implications for the cytology laboratory The Journal of American Society for Cytopathology

Coronavirus disinfection in histopathology

RCPath Briefing on Testing for COVID-19

RCPath guidance for remote digital pathology

AAPT RCPath advice Guidance for care of deceased during COVID-19 pandemic

RCPath advice on multidisciplinary team meetings during infectious disease outbreaks

PHE COVID-19: safe handling and processing for samples in laboratories

Guidance on infection prevention and control for COVID-19

NHS Guidance on Coronavirus